We continue to push the boundaries of Alzheimer’s disease research, building on the understanding of the roles of amyloid plaques and neurofibrillary tangles. Our Scientific Director and the Interim Head of the Neurodegeneration Research Unit, Heike Hering, along with our Alzheimer’s disease research and development team, are leading the way in developing treatments that could make a real difference for people living with Alzheimer’s disease. Learn more about our ongoing research here: https://ow.ly/cON150UQlNs #AlzheimersDisease
About us
Founded in 1978, Biogen is a leading biotechnology company that pioneers innovative science to deliver new medicines to transform patients’ lives and to create value for shareholders and our communities. We apply deep understanding of human biology and leverage different modalities, to advance first-in-class treatments or therapies that deliver superior outcomes. Our approach is to take bold risks, balanced with return on investment to deliver long-term growth. With approximately 7,000 people worldwide, we are truly a global organization, headquartered in Cambridge, Massachusetts, which is also home to our research operations. Our international headquarters are based in Baar, Switzerland and we have world-class manufacturing facilities in North Carolina and Solothurn, Switzerland. We offer therapies globally through direct affiliate presence in 30 countries and a network of distribution partners in over 50 additional countries. For more information, please visit www.biogen.com. Community Guidelines: https://www.biogen.com/community-guidelines.html Follow us on social media – LinkedIn, Facebook, X, and YouTube.
- Website
-
http://www.biogen.com
External link for Biogen
- Industry
- Biotechnology Research
- Company size
- 5,001-10,000 employees
- Headquarters
- Cambridge, MA
- Type
- Public Company
Locations
-
Primary
Get directions
225 Binney Street
Cambridge, MA 02142, US
-
Get directions
Landis & Gyr-Strasse 3
Zug, CH 6300, CH
-
Get directions
P.O. Box 14627
5000 Davis Drive
Research Triangle Park, NC 27709, US
Employees at Biogen
-
Bjoern Rosner
Executive Leader | Digital Operations | Biotech | Pharma | Driving product commercialization and digital innovation from conception to deployment…
-
Saleem Hussaini
Business Technology Leader | Life Sciences | @Biogen
-
Frode Hellesnes
-
Stavros Platakis
Global Head Customer Excellence and Operations BBU at Biogen
Updates
-
🎥 Neues Jahr, neues Format: #FokusBiotech! 🔍 Warum sterben Nervenzellen ab? Was geschieht bei Krankheiten wie ALS oder SMA? Diese spannenden Fragen nehmen wir in unserem neuen Wissenschaftsformat #FokusBiotech unter die Lupe! 🔬 Hier tauchen wir tief in biotechnologische und medizinische Themen ein, erklären aktuelle Fortschritte und machen komplexe Zusammenhänge greifbar. In unserer ersten Folge dreht sich alles um die Geheimnisse unserer Nervenzellen und was passiert, wenn sie nicht richtig arbeiten. 🧬Schauen Sie vorbei und entdecken Sie die Welt der Wissenschaft mit uns! #WissenschaftErklärt #MedizinischeFortschritte #Biotechnologie #Wissenschaft
-
We’re proud to announce with Eisai, the U.S. Food and Drug Administration has approved a maintenance dose option for people living with Alzheimer's disease (AD). This approval is part of our commitment to advancing AD care options. Learn more about this milestone: https://ow.ly/7bTv50UNKtk #News
-
We have announced that the U.S. Food and Drug Administration and the European Medicines Agency have accepted our marketing applications for an investigational form of a spinal muscular atrophy (SMA) therapy. Learn more about our commitment to advancing research and addressing the needs of the SMA community: https://lnkd.in/g25_73F8 #News
-
Biogen will report Q4 and full year 2024 financial results on February 12 before markets open in the U.S. Learn more: https://ow.ly/8rha50UL9wz #News | #Earnings | $BIIB
-
At our West Coast Hub, Donna leads biomarker and bioanalytical sciences. Discover her extensive career journey and how you can join her collaborative, solutions-oriented team of scientists: https://ow.ly/fsu350UKnXH #TeamBiogen
-
-
Biogen students grow professionally and personally through their experiences and impact as part of Team Biogen. Watch as they share their unique experiences. Explore our 2025 internship opportunities available now: https://ow.ly/uPkJ50UHgMh
-
Applications are now open for our Worldwide Medical Ph.D. Fellowship. This two-year program provides recent doctoral graduates with a hands-on introduction to the biotech industry and a career in medical affairs. To apply, please submit your resume and cover letter by March 31st. Apply now: https://ow.ly/N81X50UH2aV
-
-
As we expand further into immunology, we continue to make strategic investments in resources and talent to sharpen our expertise. Today, we are pleased to welcome Dr. Nick Wilson as the new Head of our Immunology Research Unit. Discover more about our scientific areas of interest: https://ow.ly/zi6M50UGcXE
-
-
Our treatment for Alzheimer's disease with Eisai has achieved a significant milestone with the completion of the filing submission to the U.S. Food and Drug Administration. This brings us one step closer to delivering much-needed options to patients in the United States. Learn more about this news: https://lnkd.in/eyKtQvaZ #News
Affiliated pages
Similar pages
Browse jobs
Stock
BIIB
NASDAQ
20 minutes delay
$146.23
1.82 (1.26%)
- Open
- 145.84
- Low
- 145.24
- High
- 147.64
Data from Refinitiv
See more info on